2024 Brain Health Academy
UsAgainstAlzheimer’s is bringing back its Brain Health Academy in May 2024. First launched in 2022, the Academy offers a free, comprehensive virtual program designed to equip healthcare providers and wellness professionals with the necessary tools and resources to reduce the risks associated with Alzheimer’s and related dementias. In collaboration with the American Society on Aging, participants will receive free continuing education credits to enhance their professional development and growth. Learn more about how you can access this resource today.
Vivian Vasallo Appointed Vice President for Early Detection
UsAgainstAlzheimer’s is pleased to announce the appointment of Vivian Vasallo as Vice President of Early Detection. In this role, Vasallo will lead and manage the efforts at UsAgainstAlzheimer’s to identify Alzheimer’s disease in its earliest stages.
Bill Increases Funding for Alzheimer’s Research and Prevention Efforts
As part of a budget bill heading to President Biden for his signature, Congress passed major investments in the fight against Alzheimer’s; specifically demonstrating its unwavering commitment to equity and inclusion in the reporting language, which helps to foster a more equitable and just healthcare system.
Important Alzheimer’s Bills Advance in Congress
Bills reinforce Alzheimer’s as a national priority, strengthen national response, and increase accountability in federal spending
Organizations Unite to Improve Brain Health
UsAgainstAlzheimer’s Launches Business Collaborative for Brain Health with founding partners AARP, GN Group, Eli Lilly, and Novo Nordisk, to improve brain health in the workforce.
Join US today
Become a Member of UsAgainstAlzheimer's and join a movement of people who don’t just talk about the Alzheimer’s crisis, but boldly step forward to become part of the solution. Defeating Alzheimer’s will take all of US. With your help, we can create a world where brain span matches lifespan.
2024 Brain Health Academy
New Vice President for Early Detection
Congress Passes Bill Making Major Investments in Alzheimer’s
Important Alzheimer’s Bills Advance in Congress
Organizations Unite to Improve Brain Health
Join US today
UsAgainstAlzheimer’s is engaged in a relentless pursuit to end Alzheimer’s, the sixth leading killer in America. Our work centers on prevention, early detection and diagnosis, and access to treatments – all regardless of gender, race, or ethnicity. To achieve our mission, we give voice to patients and caregivers while partnering with government, scientists, the private sector, and allied organizations -- the people who put the “Us” in UsAgainstAlzheimer’s.
Alzheimer’s is not a normal part of aging. There are things we can all do to reduce our risk, like eating a healthy diet, exercising, and getting good sleep. People need to know what’s good for the body is good for the brain. Learn more about our prevention work and how you can take charge of your brain health.
Early detection and diagnosis give people a better chance of managing the disease. On top of that, current treatments are most effective with patients in the early stages of dementia.
Find out how we are raising awareness of the importance of early detection and how BrainGuide is helping people concerned about their brain health start a conversation with their doctor.
We are working on multiple fronts to get safe and effective treatments into the hands of people who need them most. That includes working to ensure Alzheimer’s patients are treated fairly as the federal government considers drug approval and Medicare coverage for treatments.
See how else UsAgainstAlzheimer’s is fighting for access to treatments.
Center for Brain Health Equity
Most Alzheimer’s patients are women, Latinos, and Black people. As a patient-centered organization, all our work is done with equity in mind, so we are addressing needs of the people who are most heavily impacted by the disease. Learn more about how UsAgainstAlzheimer’s Center for Brain Health Equity is working toward a healthcare system that works for everyone.